Related Experiment Videos
Red cell membrane protein in antibody induced haemolytic anaemia
British Journal of Haematology
|October 1, 1973
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Pharmacokinetics, safety and efficacy of a recombinant factor IX product, trenonacog alfa in previously treated haemophilia B patients.
Haemophilia : the official journal of the World Federation of Hemophilia·2017
Long-term surveillance for human anti-murine antibodies of a group of haemophiliacs treated only with immunoaffinity-purified FVIII concentrates.
Haemophilia : the official journal of the World Federation of Hemophilia·2016
F8 haplotype and inhibitor risk: results from the Hemophilia Inhibitor Genetics Study (HIGS) Combined Cohort.
Haemophilia : the official journal of the World Federation of Hemophilia·2012
Potency and mass of factor VIII in FVIII products.
Haemophilia : the official journal of the World Federation of Hemophilia·2008
The need for previously untreated patient population studies in understanding the development of factor VIII inhibitors.
Haemophilia : the official journal of the World Federation of Hemophilia·2006
Inhibitor development in patients receiving recombinant factor VIII (Recombinate rAHF/Bioclate): a prospective pharmacovigilance study.
Haemophilia : the official journal of the World Federation of Hemophilia·2004
Functional assessment of inherited myeloid neoplasm-associated SAMD9L germline variants via Monoallelic CRISPR modelling.
British journal of haematology·2026
Sickle cell disease and commercial aviation. A retrospective analysis of in-flight and pre-flight medical events.
British journal of haematology·2026
LTB-TREAT: A validated international prognostic model for time to treatment in low tumour burden follicular lymphoma.
British journal of haematology·2026
Autoimmune neutropenia in children: Test cells versus beads and a role for pro-LL-37 and absolute neutrophil count.
British journal of haematology·2026
Real-world outcomes of ide-cel and cilta-cel in relapsed/refractory multiple myeloma: A nationwide, retrospective analysis in Austria.
British journal of haematology·2026
Successful treatment of refractory hemophagocytic lymphohistiocytosis complicating Epstein-Barr virus-positive classic Hodgkin lymphoma with rituximab.
Journal of clinical and experimental hematopathology : JCEH·2026
[Complement-coagulation crosstalk in immunothrombosis].
[Rinsho ketsueki] The Japanese journal of clinical hematology·2026
[Hematological diseases caused by excessive complement activation].
[Rinsho ketsueki] The Japanese journal of clinical hematology·2026
[Thiotepa-busulfan-fludarabine conditioning in allogeneic hematopoietic stem cell transplantation for blast-phase myeloproliferative neoplasm].
[Rinsho ketsueki] The Japanese journal of clinical hematology·2026
[Utility of global coagulation assays for hemostasis management in hyperclearance-type autoimmune acquired coagulation factor V deficiency].
[Rinsho ketsueki] The Japanese journal of clinical hematology·2026
Association of Pretreatment Hepatic Function Markers with Clazosentan-Associated Fluid Retention in Patients with Subarachnoid Hemorrhage.
Biological & pharmaceutical bulletin·2026